Industry Strength Score
21/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
SINGULAR GENOMICS SYSTEMS IN (OMIC) Stock Price & Overview
NASDAQ:OMIC • US82933R3084
Current stock price
20.01 USD
+0.05 (+0.25%)
Last:
The current stock price of OMIC is 20.01 USD. Today OMIC is up by 0.25%. In the past month the price increased by 0.6%. In the past year, price increased by 21.27%.
OMIC Key Statistics
52-Week Range5.34 - 23.41
Current OMIC stock price positioned within its 52-week range.
1-Month Range19.71 - 20.27
Current OMIC stock price positioned within its 1-month range.
- Market Cap
- 50.625M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -35.09
- Dividend Yield
- N/A
OMIC Stock Performance
Today
+0.25%
1 Week
+0.60%
1 Month
+0.60%
3 Months
-6.58%
Longer-term
6 Months +215.62%
1 Year +21.27%
2 Years -68.98%
3 Years -91.90%
5 Years N/A
10 Years N/A
OMIC Stock Chart
OMIC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to OMIC. When comparing the yearly performance of all stocks, OMIC is one of the better performing stocks in the market, outperforming 75.64% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
OMIC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OMIC. While OMIC seems to be doing ok healthwise, there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
OMIC Earnings
On November 12, 2024 OMIC reported an EPS of -6.72 and a revenue of 406.00K. The company beat EPS expectations (18.16% surprise) and missed revenue expectations (-51.75% surprise).
Next Earnings DateMar 17, 2025
Last Earnings DateNov 12, 2024
PeriodQ3 / 2024
EPS Reported-$6.72
Revenue Reported406K
EPS Surprise 18.16%
Revenue Surprise -51.75%
OMIC Forecast & Estimates
8 analysts have analysed OMIC and the average price target is 12.7 USD. This implies a price decrease of -36.54% is expected in the next year compared to the current price of 20.01.
For the next year, analysts expect an EPS growth of 11.81% and a revenue growth 9.93% for OMIC
Analysts
Analysts80
Price Target12.7 (-36.53%)
EPS Next Y11.81%
Revenue Next Year9.93%
OMIC Financial Highlights
Over the last trailing twelve months OMIC reported a non-GAAP Earnings per Share(EPS) of -35.09. The EPS increased by 8.62% compared to the year before.
Income Statements
Revenue(TTM)2.67M
Net Income(TTM)-86.32M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.27% | ||
| ROE | -70.04% | ||
| Debt/Equity | 0.04 |
Chartmill High Growth Momentum
EPS Q2Q%27.74%
Sales Q2Q%-12.12%
EPS 1Y (TTM)8.62%
Revenue 1Y (TTM)2.54%
OMIC Ownership
Ownership
Inst Owners54.77%
Shares2.53M
Float2.12M
Ins Owners14.13%
Short Float %N/A
Short RatioN/A
OMIC Industry Overview
OMIC operates in the Life Sciences Tools & Services sub-industry within the Health Care sector. This group contains 51 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
50/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
42%
Outperformed 42% of sub-industries
3 Month Rank
8%
Outperformed 8% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 51
- New Highs
- 0%
- New Lows
- 7.8%
- Average ROE
- 15%
- Average Profit Margin
- 15.8%
- Average Operating Margin
- 18.7%
- Average P/E
- 33.5
- Average Fwd P/E
- 28.8
- Average Debt/Equity
- 0.8
OMIC Competitors/Peers
The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 17.32 | 177.991B | ||
| DHR | DANAHER CORP | 19.03 | 126.643B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.35 | 44.626B | ||
| A | AGILENT TECHNOLOGIES INC | 17.04 | 32.654B | ||
| WAT | WATERS CORP | 21.12 | 30.357B | ||
| IQV | IQVIA HOLDINGS INC | 12.3 | 26.586B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.98 | 25.851B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 33.45 | 21.45B | ||
| ILMN | ILLUMINA INC | 22.75 | 19.253B | ||
| MEDP | MEDPACE HOLDINGS INC | 21.57 | 11.957B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.953B | ||
| RVTY | REVVITY INC | 15.75 | 9.684B | ||
| TECH | BIO-TECHNE CORP | 24.77 | 8.655B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OMIC
Company Profile
Singular Genomics Systems Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 255 full-time employees. The company went IPO on 2021-05-27. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The firm has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The firm is also engaged in developing PX, which is a development-stage multiomics platform.
Company Info
IPO: 2021-05-27
SINGULAR GENOMICS SYSTEMS IN
3010 Science Park Road
San Diego CALIFORNIA US
CEO: Andrew Spaventa
Employees: 255
Phone: 18583337830
SINGULAR GENOMICS SYSTEMS IN / OMIC FAQ
What does SINGULAR GENOMICS SYSTEMS IN do?
Singular Genomics Systems Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 255 full-time employees. The company went IPO on 2021-05-27. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The firm has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The firm is also engaged in developing PX, which is a development-stage multiomics platform.
What is the current price of OMIC stock?
The current stock price of OMIC is 20.01 USD. The price increased by 0.25% in the last trading session.
What is the dividend status of SINGULAR GENOMICS SYSTEMS IN?
OMIC does not pay a dividend.
What is the ChartMill rating of SINGULAR GENOMICS SYSTEMS IN stock?
OMIC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is SINGULAR GENOMICS SYSTEMS IN (OMIC) stock traded?
OMIC stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for OMIC stock?
SINGULAR GENOMICS SYSTEMS IN (OMIC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-35.09).
Can you provide the number of employees for SINGULAR GENOMICS SYSTEMS IN?
SINGULAR GENOMICS SYSTEMS IN (OMIC) currently has 255 employees.